0001209191-18-040492.txt : 20180702
0001209191-18-040492.hdr.sgml : 20180702
20180702191025
ACCESSION NUMBER: 0001209191-18-040492
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180701
FILED AS OF DATE: 20180702
DATE AS OF CHANGE: 20180702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goldberg Jeff Marc
CENTRAL INDEX KEY: 0001703061
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38137
FILM NUMBER: 18934379
MAIL ADDRESS:
STREET 1: C/O AKCEA THERAPEUTICS
STREET 2: 55 CAMBRIDGE PARKWAY, STE 100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001662524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472608175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 55 CAMBRIDGE PARKWAY
STREET 2: SUITE 100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 760-603-2732
MAIL ADDRESS:
STREET 1: 2855 GAZELLE CT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-01
0
0001662524
AKCEA THERAPEUTICS, INC.
AKCA
0001703061
Goldberg Jeff Marc
C/O AKCEA THERAPEUTICS, INC.
55 CAMBRIDGE PARKWAY
CAMBRIDGE
MA
02142
0
1
0
0
Chief Operating Officer
Common Stock
2018-07-01
4
J
0
1398
14.773
A
2387
D
Although not required, the Reporting Person is voluntarily reporting the acquisition of 1,398 shares on July 1, 2018 pursuant to the Issuer's
Employee Stock Purchase Plan.
/s/ Jeffrey M. Goldberg
2018-07-02